JAK-ing up chronic actinic dermatitis with upadacitinib

Author:

Pappa Georgia1,Sgouros Dimitrios1,Kanelleas Antonios1,Koumaki Dimitra2,Bozi Evangelia1,Katoulis Alexandros1

Affiliation:

1. 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, ‘ATTIKON’ General University Hospital , Athens, Greece

2. Dermatology Department, University Hospital of Heraklion , Heraklion , Greece

Abstract

We describe a unique and significant case of a 75-year-old man successfully treated with upadacitinib for chronic actinic dermatitis.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Reference5 articles.

1. Chronic actinic dermatitis revisited;Wang;Dermatitis,2020

2. Chronic actinic dermatitis;Paek;Dermatol Clin,2014

3. Chronic actinic dermatitis;Huang;CMAJ,2018

4. Upadacitinib for moderate to severe atopic dermatitis;Navarro-Triviño;Immunotherapy,2023

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Chronic actinic dermatitis;Indian Journal of Skin Allergy;2024-04-18

2. Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib;Clinical, Cosmetic and Investigational Dermatology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3